Article
Biallelic ATM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 20 Dec 2012
Skowronska Anna, Parker Anton, Ahmed Gulshanara, Oldreive Ceri, Davis Zadie, Richards Sue, Dyer Martin, Matutes Estella, Gonzalez David, Taylor A Malcolm R, Moss Paul, Thomas Peter, Oscier David, Stankovic Tatjana
Abstract excerpt
PURPOSE: The prognostic significance of ATM mutations in chronic lymphocytic leukemia (CLL) is unclear. We assessed their impact in the context of a prospective randomized trial. PATIENTS AND METHODS: We analyzed the ATM gene in 224 patients treated on the Leukemia Research Fund Chronic Lymphocytic Leukemia 4 (LRF-CLL4) trial with chlorambucil or fludarabine with and without cyclophosphamide. ATM status was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
